Related references
Note: Only part of the references are listed.Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
Jason A. Coppell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
Paul G. Richardson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Focal nodular hyperplasia of the liver following hematopoietic SCT
H. Sudour et al.
BONE MARROW TRANSPLANTATION (2009)
Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome
M. Sakai et al.
BONE MARROW TRANSPLANTATION (2009)
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
J. S. McCune et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen
Michelle Geddes et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Longitudinal analysis of heart and liver iron in thalassemia major
Leila J. Noetzli et al.
BLOOD (2008)
A problem-oriented approach to liver disease in oncology patients
G. B. McDonald et al.
GUT (2008)
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: Pharmacokinetics, liver toxicity, and mortality
Jeannine S. McCune et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project
June M. McKoy et al.
LEUKEMIA RESEARCH (2007)
Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation
Naveen Surapaneni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
Dionissios Neofytos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation
Noemi Puig et al.
LEUKEMIA & LYMPHOMA (2006)
Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies
Marco Picardi et al.
TRANSPLANTATION (2006)
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
Wendy M. Leisenring et al.
BLOOD (2006)
Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
RT Kamble et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Living-donor liver transplantation for chronic hepatic graft-versus-host disease
T Shimizu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The role of ERCP in patients with pancreatico-biliary problems in the setting of hematopoietic stem cell transplant
MM Alnusair et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia
G Marotta et al.
HEMATOLOGY (2005)
Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation
DL Coy et al.
RADIOGRAPHICS (2005)
Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation
TA Gooley et al.
HEPATOLOGY (2005)
Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors
SR Hingorani et al.
KIDNEY INTERNATIONAL (2005)
Accidental busulfan overdose during conditioning for stem cell transplantation
A Jenke et al.
BONE MARROW TRANSPLANTATION (2005)
Long-term outcome of hepatitis C infection after bone marrow transplantation
RP de Latour et al.
BLOOD (2004)
Pre-emptive use of lamivudine in bone marrow transplantation with chronic hepatitis B virus infection
M Deschênes et al.
HEPATOLOGY (2004)
Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin M syndrome with cholangiopathy
DA Jacobsohn et al.
PEDIATRICS (2004)
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
M de Lima et al.
BLOOD (2004)
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients
WJ Hogan et al.
BLOOD (2004)
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation
GB McDonald et al.
BLOOD (2003)
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation
T Ruutu et al.
BLOOD (2002)
Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale
PA Carpenter et al.
BLOOD (2002)
Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease)
LD DeLeve et al.
SEMINARS IN LIVER DISEASE (2002)
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen
GKK Lau et al.
GASTROENTEROLOGY (2002)
Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis
SI Strasser et al.
HEPATOLOGY (2000)
Hyperammonemia after high-dose chemotherapy and stem cell transplantation
P Frere et al.
BONE MARROW TRANSPLANTATION (2000)
Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir
T Yagi et al.
BONE MARROW TRANSPLANTATION (2000)
Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes
LD DeLeve et al.
PHARMACOLOGY (2000)
Share Paper
